Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prolonged use of tedizolid in a pulmonary non-tuberculous mycobacterial infection after linezolid-induced toxicity.

× No keyword cloud information.

15 in total

1. Invasive Mycobacterium abscessus Complex Infection After Cardiac Surgery: Epidemiology, Management, and Clinical Outcomes.

Authors: Arthur W Baker; Eileen K Maziarz; Sarah S Lewis; Jason E Stout; Deverick J Anderson; Peter K Smith; Jacob N Schroder; Mani A Daneshmand; Barbara D Alexander; Richard J Wallace; Daniel J Sexton; Cameron R Wolfe
Journal: Clin Infect Dis Date: 2021-04-08 Impact factor: 9.079

2. In Vitro Activity of Tedizolid against Mycobacterium tuberculosis.

Authors: Pilar Ruiz; Manuel Causse; Manuel Vaquero; Manuel Casal
Journal: Antimicrob Agents Chemother Date: 2019-03-27 Impact factor: 5.191

Review 3. Skin and Soft Tissue Infections Due to Nontuberculous Mycobacteria.

Authors: Elizabeth Ann Misch; Christopher Saddler; James Muse Davis
Journal: Curr Infect Dis Rep Date: 2018-03-19 Impact factor: 3.725

4. In Vitro Susceptibility Testing of Tedizolid against Isolates of Nocardia.

Authors: Barbara A Brown-Elliott; Richard J Wallace
Journal: Antimicrob Agents Chemother Date: 2017-11-22 Impact factor: 5.191

5. Mitochondrial Alterations (Inhibition of Mitochondrial Protein Expression, Oxidative Metabolism, and Ultrastructure) Induced by Linezolid and Tedizolid at Clinically Relevant Concentrations in Cultured Human HL-60 Promyelocytes and THP-1 Monocytes.

Authors: Tamara V Milosevic; Valéry L Payen; Pierre Sonveaux; Giulio G Muccioli; Paul M Tulkens; Françoise Van Bambeke
Journal: Antimicrob Agents Chemother Date: 2018-02-23 Impact factor: 5.191

6. In vitro Susceptibility of Nontuberculous Mycobacteria to Tedizolid.

Authors: Huiyun Zhang; Wenya Hua; Siran Lin; Yu Zhang; Xinchang Chen; Shiyong Wang; Jiazhen Chen; Wenhong Zhang
Journal: Infect Drug Resist Date: 2022-08-25 Impact factor: 4.177

Review 7. NTM drug discovery: status, gaps and the way forward.

Authors: Mu-Lu Wu; Dinah B Aziz; Véronique Dartois; Thomas Dick
Journal: Drug Discov Today Date: 2018-04-07 Impact factor: 7.851

8. Arthroscopic "Debridement and Implant Retention" With Local Administration of Exebacase (Lysin CF-301) Followed by Suppressive Tedizolid as Salvage Therapy in Elderly Patients for Relapsing Multidrug-Resistant S. epidermidis Prosthetic Knee Infection.

Authors: Tristan Ferry; Cécile Batailler; Aubin Souche; Cara Cassino; Christian Chidiac; Thomas Perpoint; Claire le Corvaisier; Jérôme Josse; Romain Gaillard; Julien Roger; Camille Kolenda; Sébastien Lustig; Frédéric Laurent
Journal: Front Med (Lausanne) Date: 2021-05-14

Review 9. Therapeutic Drug Monitoring in Non-Tuberculosis Mycobacteria Infections.

Authors: Jan-Willem Alffenaar; Anne-Grete Märtson; Scott K Heysell; Jin-Gun Cho; Asad Patanwala; Gina Burch; Hannah Y Kim; Marieke G G Sturkenboom; Anthony Byrne; Debbie Marriott; Indy Sandaradura; Simon Tiberi; Vitali Sintchencko; Shashikant Srivastava; Charles A Peloquin
Journal: Clin Pharmacokinet Date: 2021-03-10 Impact factor: 6.447

10. Correction of Linezolid-Induced Myelotoxicity After Switch to Tedizolid in a Patient Requiring Suppressive Antimicrobial Therapy for Multidrug-Resistant Staphylococcus epidermidis Prosthetic-Joint Infection.

Authors: Tristan Ferry; Cécile Batailler; Anne Conrad; Claire Triffault-Fillit; Frédéric Laurent; Florent Valour; Christian Chidiac
Journal: Open Forum Infect Dis Date: 2018-09-25 Impact factor: 3.835